» Articles » PMID: 32879602

Recurrent Intraductal Papillary Mucinous Neoplasms of the Pancreas Mimicking Ampullary Cancer

Overview
Specialty Gastroenterology
Date 2020 Sep 4
PMID 32879602
Authors
Affiliations
Soon will be listed here.
Abstract

Although several studies have reported that some patients developed metachronous/recurrent intraductal papillary mucinous neoplasms (IPMNs) after partial pancreatectomy, recurrence of IPMN mimicking ampullary cancer is extremely rare. We report the case of a 62-year-old man who developed recurrent IPMN mimicking ampullary cancer. Every 3-6 months, the patient had received surveillance with computed tomography after distal pancreatectomy for IPMN, high-grade, pancreatobiliary type. However, a villous tumor at the major duodenal papilla was found incidentally by upper gastrointestinal endoscopy 2 years and 3 months after initial surgery, and the biopsy result was adenocarcinoma. Endoscopic ultrasonography showed a tumor at the periampullary lesion; however, the origin of the tumor could not be determined definitively. Remnant total pancreatectomy was performed, and the histological diagnosis revealed IPMN, high-grade, pancreatobiliary type. Some patients develop recurrent IPMN mimicking ampullary cancer; thus, careful surveillance for periampullary lesions as well as remnant pancreas should be performed.

References
1.
Tanaka M, Fernandez-Del Castillo C, Kamisawa T, Jang J, Levy P, Ohtsuka T . Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017; 17(5):738-753. DOI: 10.1016/j.pan.2017.07.007. View

2.
Miyasaka Y, Ohtsuka T, Tamura K, Mori Y, Shindo K, Yamada D . Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm. Ann Surg. 2015; 263(6):1180-7. DOI: 10.1097/SLA.0000000000001368. View

3.
Rezaee N, Barbon C, Zaki A, He J, Salman B, Hruban R . Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. HPB (Oxford). 2016; 18(3):236-46. PMC: 4814593. DOI: 10.1016/j.hpb.2015.10.010. View

4.
Miller J, Meyer J, Waters J, Al-Haddad M, DeWitt J, Sherman S . Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm. HPB (Oxford). 2011; 13(11):759-66. PMC: 3238009. DOI: 10.1111/j.1477-2574.2011.00354.x. View

5.
Date K, Ohtsuka T, Fujimoto T, Tamura K, Kimura H, Matsunaga T . Molecular Evidence for Monoclonal Skip Progression in Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2017; 265(5):969-977. DOI: 10.1097/SLA.0000000000001755. View